Home    Back

 Drug    DrugBank | All Description Patterns

   e.g. "Sirolimus", "Adalimumab"

A    B    C    D    E    F    G    H     I     J    K    L    M    N    O    P    Q    R    S    T    U    V    W    X    Y    Z    other

77 / 12,170 descriptions found* Show info (disease name, etc.) on mouse-over.
 No.   Drug (Description in trials)   DrugBank   KEGG DRUG *   KEGG GENES * 
 [Number of genes] 		  KEGG PATHWAY 
 [Number of pathways] 		  Disease ID * 
 [Number of diseases] 
 1   1.2 mg zgn-440 for injectable suspension   -   -   -   -   [1]
193 
 2   1.8 mg zgn-440 for injectable suspension   -   -   -   -   [1]
193 
 3   Acomplia 20 mg film-coated tablets   -   -   -   -   [1]
193 
 4   Acth   Corticotropin   D00146   [1] MC2R   [5] Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway   [5]
13,
66,
145,
193,
222 
 5   Anastrozole   Anastrozole   D00960   [1] CYP19A1   [3] Metabolic pathways, Ovarian steroidogenesis, Steroid hormone biosynthesis   [3]
78,
86,
193 
 6   Azp-531   -   -   -   -   [1]
193 
 7   B. lactis b94   -   -   -   -   [1]
193 
 8   Beloranib   Beloranib   -   -   -   [1]
193 
 9   Byetta   Exenatide   D04121   [1] GLP1R   [3] Insulin secretion, Neuroactive ligand-receptor interaction, cAMP signaling pathway   [1]
193 
 10   Cannabidiol   Cannabidiol   D10915   [2] CNR1, CNR2   [4] Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis   [13]
6,
13,
46,
95,
96,
97,
140,
144,
145,
157,
158,
193,
271 
 11   Cannabidiol oral solution   Cannabidiol   D10915   [2] CNR1, CNR2   [4] Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis   [4]
140,
144,
145,
193 
 12   Carbetocin   Carbetocin   D07229   [1] OXTR   [4] Calcium signaling pathway, Neuroactive ligand-receptor interaction, Oxytocin signaling pathway, cAMP signaling pathway   [1]
193 
 13   Cbdv   Cannabidivarin   -   -   -   [1]
193 
 14   Cbdv compound   Cannabidivarin   -   -   -   [1]
193 
 15   Chloride   Chloride ion   -   -   -   [17]
6,
11,
13,
14,
34,
46,
51,
96,
97,
127,
168,
193,
227,
228,
288,
297,
299 
 16   Choline   Choline   D07690   -   -   [4]
65,
171,
193,
299 
 17   Coenzyme q10   Ubidecarenone   D01065   -   -   [10]
2,
6,
8,
10,
46,
57,
113,
193,
214,
215 
 18   Dccr   -   -   -   -   [1]
193 
 19   Diazoxide   Diazoxide   D00294   [2] ABCC8, KCNJ11   [4] ABC transporters, GnRH secretion, Insulin secretion, Type II diabetes mellitus   [1]
193 
 20   Diazoxide choline controlled-release tablet   Diazoxide   D00294   [2] ABCC8, KCNJ11   [4] ABC transporters, GnRH secretion, Insulin secretion, Type II diabetes mellitus   [1]
193 
 21   Eu/1/06/362/003: 5µg (1 pen)   -   -   -   -   [1]
193 
 22   Eutropin   -   -   -   -   [2]
78,
193 
 23   Exenatide   Exenatide   D04121   [1] GLP1R   [3] Insulin secretion, Neuroactive ligand-receptor interaction, cAMP signaling pathway   [3]
6,
193,
233 
 24   Fe 992097   -   -   -   -   [1]
193 
 25   Genotonorm   Somatotropin   D02691   [1] GHR   [5] Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway   [1]
193 
 26   Genotonorm miniquick 0,2 mg   Somatotropin   D02691   [1] GHR   [5] Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway   [1]
193 
 27   Genotropin   Somatotropin   D02691   [1] GHR   [5] Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway   [3]
13,
78,
193 
 28   Genotropin (somatropin) is a growth hormone treatment. it is an exact copy of the natural growth hormone that our bodies make. the main difference is that genotropin is man-made.   Somatotropin   D02691   [1] GHR   [5] Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway   [1]
193 
 29   Glwl-01   -   -   -   -   [1]
193 
 30   Growth hormone   Somatotropin   D02691   [1] GHR   [5] Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway   [11]
2,
13,
19,
46,
78,
96,
191,
193,
195,
265,
299 
 31   Growth hormone (genotonorm® or omnitrope®)   Somatotropin   D02691   [1] GHR   [5] Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway   [2]
78,
193 
 32   Guanfacine   Guanfacine   D00606, D08031   [1] ADRA2A   [2] Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway   [1]
193 
 33   Guanfacine extended release (gxr)   Guanfacine   D00606, D08031   [1] ADRA2A   [2] Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway   [1]
193 
 34   Human growth hormone   Somatotropin   D02691   [1] GHR   [5] Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway   [3]
78,
193,
265 
 35   Humatrope 6 mg/12 mg/24 mg injektiokuiva-aine ja liuotin, liuosta varten   Somatotropin   D02691   [1] GHR   [5] Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway   [1]
193 
 36   Inn not yet proposed   -   -   -   -   [1]
193 
 37   Intranasal carbetocin dose 1   Carbetocin   D07229   [1] OXTR   [4] Calcium signaling pathway, Neuroactive ligand-receptor interaction, Oxytocin signaling pathway, cAMP signaling pathway   [1]
193 
 38   Intranasal carbetocin dose 2   Carbetocin   D07229   [1] OXTR   [4] Calcium signaling pathway, Neuroactive ligand-receptor interaction, Oxytocin signaling pathway, cAMP signaling pathway   [1]
193 
 39   Intranasal oxytocin   Oxytocin   D00089   [1] OXTR   [4] Calcium signaling pathway, Neuroactive ligand-receptor interaction, Oxytocin signaling pathway, cAMP signaling pathway   [2]
127,
193 
 40   Intranasal oxytocin (in-oxt)   Oxytocin   D00089   [1] OXTR   [4] Calcium signaling pathway, Neuroactive ligand-receptor interaction, Oxytocin signaling pathway, cAMP signaling pathway   [1]
193 
 41   Liraglutide   Liraglutide   D06404   [1] GLP1R   [3] Insulin secretion, Neuroactive ligand-receptor interaction, cAMP signaling pathway   [3]
6,
75,
193 
 42   Livoletide   Livoletide   -   -   -   [1]
193 
 43   Medical air   Medical air   -   -   -   [3]
85,
86,
193 
 44   Medical air vs oxygen   Medical air   -   -   -   [1]
193 
 45   Metoprolol   Metoprolol   D00601, D02358, D05011   [1] ADRB1   [10] Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Dilated cardiomyopathy (DCM), Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway   [6]
17,
57,
58,
113,
193,
226 
 46   Metoprolol succinate   Metoprolol   D00601, D02358, D05011   [1] ADRB1   [10] Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Dilated cardiomyopathy (DCM), Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway   [4]
57,
58,
113,
193 
 47   Metoprololsuccinat orion 25mg   -   -   -   -   [1]
193 
 48   Metoprololsuccinat ”orion” 25mg   -   -   -   -   [1]
193 
 49   Metyrapone   Metyrapone   D00410, D05019   [1] CYP11B1   [4] Cortisol synthesis and secretion, Cushing syndrome, Metabolic pathways, Steroid hormone biosynthesis   [2]
75,
193 
 50   Norditropin simplexx   -   -   -   -   [4]
3,
78,
193,
195 
 51   Nutropin aq   -   -   -   -   [4]
78,
134,
193,
299 
 52   Octreotide   Octreotide   D00442, D06495   [1] SSTR2   [4] Gastric acid secretion, Growth hormone synthesis, secretion and action, Neuroactive ligand-receptor interaction, cAMP signaling pathway   [7]
67,
75,
84,
85,
89,
193,
227 
 53   Omnitrope   Somatotropin   D02691   [1] GHR   [5] Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway   [2]
78,
193 
 54   Oxygen   Oxygen   D00003   -   -   [14]
46,
49,
70,
84,
85,
86,
88,
90,
96,
97,
193,
226,
299,
330 
 55   Oxytocin   Oxytocin   D00089   [1] OXTR   [4] Calcium signaling pathway, Neuroactive ligand-receptor interaction, Oxytocin signaling pathway, cAMP signaling pathway   [4]
127,
193,
206,
226 
 56   Oxytocin (oxt) continuous   Oxytocin   D00089   [1] OXTR   [4] Calcium signaling pathway, Neuroactive ligand-receptor interaction, Oxytocin signaling pathway, cAMP signaling pathway   [1]
193 
 57   Physiological serum (sodium chloride)   Sodium chloride   D02056   -   -   [1]
193 
 58   Probiotic   -   -   -   -   [5]
2,
6,
96,
193,
266 
 59   Recombinant human growth hormon   -   -   -   -   [1]
193 
 60   Recombinant human growth hormone   Somatotropin   D02691   [1] GHR   [5] Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway   [3]
78,
193,
265 
 61   Recombinant somatropin   Somatotropin   D02691   [1] GHR   [5] Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway   [1]
193 
 62   Rimonabant   Rimonabant   D05731   [1] CNR1   [4] Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis   [1]
193 
 63   Rm-493   -   -   -   -   [1]
193 
 64   Sandostatin lar   -   -   -   -   [4]
67,
84,
193,
227 
 65   Saxenda   Liraglutide   D06404   [1] GLP1R   [3] Insulin secretion, Neuroactive ligand-receptor interaction, cAMP signaling pathway   [1]
193 
 66   Sodium chloride   Sodium chloride   D02056   -   -   [13]
6,
11,
13,
14,
34,
46,
51,
168,
193,
227,
228,
288,
299 
 67   Somatropin   Somatotropin   D02691   [1] GHR   [5] Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway   [15]
2,
3,
19,
46,
74,
75,
78,
96,
113,
193,
195,
265,
274,
276,
299 
 68   Subcutaneous beloranib in suspension   Beloranib   -   -   -   [1]
193 
 69   Syntocinon   Oxytocin   D00089   [1] OXTR   [4] Calcium signaling pathway, Neuroactive ligand-receptor interaction, Oxytocin signaling pathway, cAMP signaling pathway   [2]
127,
193 
 70   Syntocinon nasal spray   Oxytocin   D00089   [1] OXTR   [4] Calcium signaling pathway, Neuroactive ligand-receptor interaction, Oxytocin signaling pathway, cAMP signaling pathway   [1]
193 
 71   Syntocinon®/- spray   -   -   -   -   [1]
193 
 72   Tesofensine   Tesofensine   -   -   -   [2]
6,
193 
 73   Tesofensine/metoprolol   Tesofensine   -   -   -   [1]
193 
 74   Topiramate   Topiramate   D00537   [36] CA2, CA4, CACNA1C, CACNA1D, CACNA1F, CACNA1S, GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ, GRIA1, GRIA2, GRIA3, GRIA4, GRIK1, GRIK2, GRIK3, GRIK4, GRIK5, SCN1A, SCN2A, SCN3A, SCN5A, SCN9A   [48] Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis (ALS), Arrhythmogenic right ventricular cardiomyopathy (ARVC), Bile secretion, Calcium signaling pathway, Carbohydrate digestion and absorption, Cardiac muscle contraction, Cellular senescence, Cholinergic synapse, Circadian entrainment, Cocaine addiction, Collecting duct acid secretion, Cortisol synthesis and secretion, Cushing syndrome, Dilated cardiomyopathy (DCM), Dopaminergic synapse, GABAergic synapse, Gastric acid secretion, Glutamatergic synapse, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Hypertrophic cardiomyopathy (HCM), Insulin secretion, Long-term depression, Long-term potentiation, MAPK signaling pathway, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Nitrogen metabolism, Oxytocin signaling pathway, Pancreatic secretion, Proximal tubule bicarbonate reclamation, Renin secretion, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction, Tight junction, Transcriptional misregulation in cancer, Type II diabetes mellitus, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway   [5]
6,
140,
144,
156,
193 
 75   Zgn-440   -   -   -   -   [1]
193 
 76   Zgn-440 for injectable suspension   -   -   -   -   [1]
193 
 77   Zgn-440 sterile diluent   -   -   -   -   [1]
193 

Back to top